Vise Technologies’s Medline Inc MDLN Stock Holding History

Vise Technologies’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$206K	Buy	+5,950	New	+$218K	﹤0.01%	1962

Other funds holding MDLN

Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Cullen/Frost Bankers San Antonio, Texas $10.2B AUM 22.58% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Vise Technologies's MDLN Position: Q3 2026 in Review

Vise Technologies opened a new position in Medline Inc (MDLN) in Q3 2026: 5,950 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #1962 among its holdings.

116 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

Vise Technologies held 5,950 shares of Medline Inc worth $206K as of Q3 2026.
Medline Inc was a new Vise Technologies position in Q3 2026.
Medline Inc made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #1962 holding.
116 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.